A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy.
about
Can urinary exosomes act as treatment response markers in prostate cancer?Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate CancerEmerging critical role of molecular testing in diagnostic genitourinary pathologyThe Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer.The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.The novel prostate cancer antigen 3 (PCA3) biomarker.A multiplex assay to measure RNA transcripts of prostate cancer in urine.The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer.Risk stratification of prostate cancer in the modern era.Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.Regulators of gene expression as biomarkers for prostate cancerPersonalized management in low-risk prostate cancer: the role of biomarkers.Prostate cancer markers: An update.Personalized prostate cancer care: from screening to treatment.Markers for detection of prostate cancer.Urine markers in monitoring for prostate cancer.Active surveillance for favorable-risk prostate cancer: a short review.Active surveillance for low-risk prostate cancer: an update.Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.Molecular biomarkers in prostate cancer.PCA3 in the detection and management of early prostate cancer.Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancer.The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL.Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of PlayProgensa™ PCA3 test for prostate cancer.Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins.PCA3 as a diagnostic marker for prostate cancer: a validation study on a Swedish patient population.
P2860
Q21245467-E136527F-4852-4EBE-BF68-4DBD3E8A195EQ26767044-8ABFE51B-B3C3-41D9-B9B2-7E33DBAA906AQ27021371-5A986916-620D-48D0-92D8-9F467FFC8189Q33922385-B57632CF-5315-4A20-A205-64951570471EQ34143522-97836746-FFDC-4BC3-A8CE-69B9E21FC9B8Q34156075-DDE4EA97-DABD-418B-A9A7-4EB5B15D04BFQ34429720-C579D806-F8B1-4BD2-B3BC-47AC59C8547FQ34984413-5880C016-E181-4496-BCF5-5A7759BBF0C2Q35680101-28E7CEA0-9A40-451A-B842-E6DE15C62D93Q36190604-35779A0F-05D6-457F-BC45-A569E1CBA80CQ36439912-B736CCAF-4E82-4C1B-B397-615F7A32A0B6Q36495701-2B286C66-9356-4029-A7D0-F3526F836B66Q36640109-6BA12A59-9FD9-493C-9E56-F857799F6F17Q37113160-DC35698E-BB57-4646-861E-161FED45893BQ37328403-0AE86EE3-2C69-4517-B518-186EDE947ABDQ37571461-48D5EBF7-4AF2-4FBC-817E-279C1068A838Q37804698-43E695DE-5647-4C0F-BB04-BE712EDFC428Q37868926-7378D391-E950-460E-A370-B4E480CD9B9DQ37945288-466C8930-EAF0-4621-ABE0-5D5530FEC4D7Q38088854-67AF28AA-3948-4FE1-A20E-5FDBC6B5A318Q38090552-263ACDCA-03CA-4364-A0D2-C455660B8E8EQ38144712-C3EB1960-95E0-4A54-8B4C-E105F1D0CE23Q38191938-77651471-EE5A-4F48-A10B-ED16AA95D574Q38394519-A47509A9-D1A8-408C-9B68-6F7FC950AB4DQ39375743-72E1CC58-3389-445A-B9BF-8054263C5B31Q39771683-4AC538CF-3670-4F37-8840-C6BE46653722Q47136739-274BDFD5-5DBF-4EAC-BBD6-C0D2B92C2210Q51747556-3ADB3EC8-43D0-4C27-B93C-21510B04D7FF
P2860
A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@ast
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@en
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@nl
type
label
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@ast
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@en
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@nl
prefLabel
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@ast
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@en
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@nl
P2093
P1433
P1476
A multicenter evaluation of th ...... ance, and diagnostic accuracy.
@en
P2093
Debra J Elliott
Harry Rittenhouse
Ina L Deras
Jack Groskopf
Jennifer Noteboom
Lori J Sokoll
Mark Sarno
Paul Lange
Robert L Vessella
P356
10.1016/J.CCA.2007.11.003
P577
2007-11-17T00:00:00Z